Download PDFOpen PDF in browserPersonalized Medicine and PharmacogenomicsEasyChair Preprint 1503915 pages•Date: September 24, 2024AbstractPersonalized medicine represents a paradigm shift in healthcare, focusing on tailoring medical treatment to individual characteristics, such as genetics, lifestyle, and environment. Pharmacogenomics, a key component of personalized medicine, explores how genetic variations influence drug response. This field enables the development of precise medical therapies, reducing adverse drug reactions and optimizing drug efficacy. By integrating genetic data into clinical decision-making, pharmacogenomics allows for customized treatment plans that enhance patient outcomes. Despite significant progress, challenges remain in the implementation of personalized medicine, including ethical concerns, high costs, and the need for widespread genetic literacy among healthcare providers. Continued research and advancements in genomic technologies will be critical in overcoming these obstacles and fully realizing the potential of personalized medicine. Keyphrases: Aurora kinase, BET, Bromodomain, CDK, CDK9, Epigenetics, cancer, computer-aided drug design, dual inhibitor, inhibitor, kinase
|